Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion
|ClinicalTrials.gov Identifier: NCT00383773|
Recruitment Status : Unknown
Verified September 2006 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : October 4, 2006
Last Update Posted : October 4, 2006
|Condition or disease||Intervention/treatment||Phase|
|Central Retinal Vein Occlusion||Procedure: Retinal endo vascular surgery||Not Applicable|
Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations.
Patient will be operated vitrectomy, and a branch retinal vein will be punctured by small needle and rTPA 200mcg/ml will be injected to the vein.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||October 2006|
|Estimated Study Completion Date :||October 2007|
- Visual acuity
- Amount of macular edema.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00383773
|Contact: Michael Halpert, MD.||firstname.lastname@example.org|
|Contact: Hadas Lemberg, PhD||0097226777572||Ihadas@hadassah.org.il|
|Study Chair:||Michael halpert||Hadassah Medical Organization|